Results 31 to 40 of about 4,518,294 (325)

Essentials of Herb-Drug Interactions in the Elderly With Cardiovascular Disease

Journal of Patient-Centered Research and Reviews, 2015
As the number of individuals, particularly the elderly, using herbal products with prescription drugs continues to grow, the risk for adverse interactions increases but remains poorly recognized. The true incidence and nature of adverse herb reactions or
Sulaiman Sultan, Maria Viqar, Rabaiya Ali, A. Jamil Tajik, Arshad Jahangir   +4 more
doaj   +1 more source

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Bioscience Reports, 2019
Diabetics have higher morbidity and mortality in cardiovascular disease (CVD). A variety of antidiabetic agents are available for clinical choice. Cardiovascular (CV) safety assessment of these agents is crucial in addition to hypoglycemic effect before ...
Qingguo Lu, Xuan Li, Jia Liu, Xiaodong Sun, Thomas V. Rousselle, Di Ren, N. Tong, Ji Li   +7 more
semanticscholar   +1 more source

New antiplatelet agents for cardiovascular disease [PDF]

Canadian Medical Association Journal, 2013
Antiplatelet therapy is a key component in the management of many medical diseases to decrease the risk of cardiovascular events.[1][1] Acetylsalicyclic acid (ASA) is the most common antiplatelet agent used and is usually first-line therapy. Use of clopidogrel, especially in combination with ASA,
Cesilia Nishi, Doson Chua
openaire   +3 more sources

What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I

Netherlands Heart Journal, 2013
IntroductionSeveral cardiovascular agents, such as diuretics and β-blockers, can negatively affect sexual function, leading to noncompliance with therapy. Others such as angiotensin II receptor blockers (ARBs) can improve patients’ sexual function.AimsWe
M. Nicolai, S. Liem, S. Both, R. Pelger, H. Putter, M. Schalij, H. Elzevier   +6 more
semanticscholar   +1 more source

Frequency domain analysis of photoplethysmographic and arterial pressure waveforms for assessing hemodynamics in children with congenital heart surgery [PDF]

Korean Journal of Anesthesiology
Background Time-domain parameters are less reliable in children due to increased arterial and chest wall compliance. We assessed the ability of indices derived from frequency analysis of photoplethysmography (PPG) and arterial blood pressure (ABP ...
Hwa-Young Jang, In-Kyung Song, Sung-Hoon Kim, Won-Jung Shin   +3 more
doaj   +1 more source

Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40–69 year olds

BMC Cardiovascular Disorders, 2020
Background Uncontrolled hypertension is a major cardiovascular risk factor. We examined uncontrolled hypertension and differences in treatment regimens between a high-risk country, Russia, and low-risk Norway to gain better understanding of the ...
Jakob Petersen, Sofia Malyutina, Andrey Ryabikov, Anna Kontsevaya, Alexander V. Kudryavtsev, Anne Elise Eggen, Martin McKee, Sarah Cook, Laila A. Hopstock, Henrik Schirmer, David A. Leon   +10 more
doaj   +1 more source

Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease

Journal of Diabetes Investigation, 2022
Cardiovascular (CV) disease is the most alarming complication of diabetes mellitus (DM), and a strategy aiming at cardiovascular event prevention in diabetes mellitus has long been debated.
Hiroaki Yagyu, Hitoshi Shimano
doaj   +1 more source

More hemodynamic changes in hypertensive versus non-hypertensive patients undergoing breast cancer surgery in general anesthesia - a prospective clinical study [PDF]

Medicinski Glasnik, 2009
Aim Preoperative comorbidity may significantly influence theconduction of anesthesia and patients’ outcome. The aim of thisstudy was to compare a number of anesthetic interventions and theuse of non-anesthetic drugs in hypertensive and non ...
Darija Azenić-Venžera, Kata Šakić, Jozo Kristek, Ivana Drenjančević-Haršanji, Andreja Rakipović-Stojanović, Gordana Brozovic, Slavica Kvolik, Dražen Vidović, Borna Kovačić, Gordana Kristek   +9 more
doaj  

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes

Cardiovascular Diabetology, 2017
BackgroundIncretin-based agents, including dipeptidyl peptidase-4 inhibitors (DPP-4Is) and glucagon-like peptide-1 agonists (GLP-1As), work via GLP-1 receptor for hyperglycemic control directly or indirectly, but have different effect on cardiovascular ...
Zeqing Zhang, Xi Chen, Puhan Lu, Jian-hua Zhang, Yongping Xu, Wentao He, Mengni Li, Shujun Zhang, Jing Jia, S. Shao, Jun-hui Xie, Yan Yang, Xuefeng Yu   +12 more
semanticscholar   +1 more source

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.

Circulation, 2022
Patients with type 2 diabetes are at high risk for development of cardiovascular disease, including myocardial infarction, stroke, heart failure, and cardiovascular death.
N. Marx, M. Husain, M. Lehrke, S. Verma, N. Sattar   +4 more
semanticscholar   +1 more source